IP Library Granted Patent US 7,135,285
Granted Patent B2
US 7,135,285 · App. 10/099,442 · Granted Nov 14, 2006

Identification of molecular sequence signatures and methods involving the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,135,285
App. No.
10/099,442
Granted
Nov 14, 2006
Kind
B2
Abstract

Novel means and methods for analyzing hybridization data derived from hybridization assays between a target nucleic acid and differently sequenced polynucleotide probes involve selecting probe sets that define reference sequences for sequence signatures and deriving useful data about the nature of the target nucleic acid molecule based on its hybridization to the probes. The methods are useful for determining whether the target contains a nucleic acid or polypeptide sequence signature, whether the target encodes a member of a gene family, or whether the target is derived from one of any number of genes.

Claims (11)

1. A method for determining whether a DNA sample contains a gene family member, said method comprising

providing a polynucleotide array comprising a polynucleotide probe that defines a reference nucleotide sequence from the gene family member wherein the reference nucleotide sequence codes for an amino acid sequence and the array further comprises a probe set defining a degenerate set of nucleotide sequences encoding said amino acid sequence;

wherein the nucleotide sequences encoding said amino acid sequence are between 15 and 30 nucleotides in length, and

wherein the probe set defining said degenerate set comprises at least 25% of the nucleotide sequences encoding said degenerate set;

hybridizing said DNA sample to said probe array;

detecting the presence or absence of a sequence in said DNA sample hybridizing to said probe set defining said degenerate set of nucleotide sequences; and

determining whether the DNA in the sample contains a member of the gene family from the presence or absence of a sequence hybridizing to said probe set defining said degenerate set of nucleotide sequences.

2. The method of claim 1 , wherein the probe set defining said degenerate set comprises at least 50% of the nucleotide sequences encoding said degenerate set.

3. The method of claim 1 , wherein the probe set defining said degenerate set comprises at least 75% of the nucleotide sequences encoding said degenerate set.

4. The method of claim 1 , wherein the probe set defining said degenerate set comprises at least 95% of the nucleotide sequences encoding said degenerate set.

5. The method of claim 1 , wherein the probe set defining said degenerate set comprises the set of all nucleotide sequences encoding said degenerate set.

Assignments (4)
NOTICE OF RELEASE Recorded Apr 5, 2016
From: BANK OF AMERICA, N.A.
To: AFFYMETRIX, INC.
Reel/Frame 038361/0891 →
RELEASE OF SECURITY INTEREST Recorded Nov 13, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
To: AFFYMETRIX, INC.
Reel/Frame 037109/0132 →
SECURITY INTEREST Recorded Oct 28, 2015
From: AFFYMETRIX, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036988/0166 →
SECURITY AGREEMENT Recorded Jun 27, 2012
From: AFFYMETRIX, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 028465/0541 →